MedPath

Development of Mealbox for Relieving Oxidative Stress in Korean Elderly with Metabolic Syndrome

Not Applicable
Completed
Conditions
Endocrine, nutritional and metabolic disease
Registration Number
KCT0004549
Lead Sponsor
Yonsei University Health System, Gangnam Severance Hospital
Brief Summary

Antioxidant rich dietary intervention for 4 weeks could reduce the state of oxidative stress and improve the components of MetS such as central obesity, hyperlipidemia and hypertension in Korean adults with MetS. These findings will provide the basic data to set up the dietary guidelines for MetS in Korean.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
31
Inclusion Criteria

The subjects who met 3 or more items of IDF criteria for metabolic syndrome were enrolled. The criteria for IDF are as follows, waist circumference (male > 90cm, Female > 80cm), serum fasting plasma glucose > 100mg/dL, serum triglyceride > 150mg/dL, serum HDL-cholesterol (male < 40mg/dL, Female < 50 mg/dL), systolic blood pressure (SBP) > 130mmHg or diastolic blood pressure (DBP) > 85mmHg.

Exclusion Criteria

current smoker
current drinker of at leasr 1 glass a day (355ml beer, 5oz wine 1.3 glass of soju)
a person who have gained or lost 5% or more of their total weight in the last month
a person who is allergic or hypersensitive reaction to certain foods
a person who are mentally ill or who don't understand the purpose and method of study, suchas those who are addicted to drugs or alcohol
a person who cannot read consent forms, such as illiteracy or foreigners
a person who do not want to participate in study or refuse to fill up consent forms.

Study & Design

Study Type
Interventional Study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
waist circumference;Blood pressure (systolic and diastolic);Lipid profile (total cholesterol, triglyceride, HDL & LDL cholesterol);Fasting plasma glucose (fasting 8-hours);oxygen radical absorbance capacity (ORAC);Advanced Glycation End products (AGEs)
Secondary Outcome Measures
NameTimeMethod
Serum C-peptide;Serum insulin;Apolipoprotein B;Body mass index (BMI);Protein carboxylation;Lipid peroxidation;Oxidized LDL;tumor necrosis factor - alpha;small dense LDL;Pulse wave velocity (PWV);Glycated hemoglobin (HbA1c);Fat measured Computed Tomography (CT)
© Copyright 2025. All Rights Reserved by MedPath